TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. (Q53278207)

12 May 2018

title

TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease. (English)

1 reference

12 May 2018

0 references

2

1 reference

12 May 2018

author name string

M M Edwards

series ordinal

1

1 reference

12 May 2018

publication date

1 June 2006

1 reference

12 May 2018

Journal of Neural Transmission

published in

1 reference

12 May 2018

volume

113

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

1709-1715

1 reference

12 May 2018

https://scigraph.springernature.com/pub.10.1007/s00702-006-0479-5

exact match

0 references

cites work

Increased permeability of primary cultured brain microvessel endothelial cell monolayers following TNF-alpha exposure.

1 reference

12 December 2020

Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.

1 reference

12 December 2020

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease.

1 reference

12 December 2020

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

1 reference

12 December 2020

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

12 December 2020

The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease

1 reference

12 December 2020

Increased S100 beta neurotrophic activity in Alzheimer's disease temporal lobe

1 reference

12 December 2020

Cytokines in Dementias

1 reference

12 December 2020

Increased S100beta in the cerebrospinal fluid of patients with frontotemporal dementia.

1 reference

12 December 2020

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

12 December 2020

Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease.

1 reference

12 December 2020

Patterns of gliosis in Alzheimer's disease and aging cerebrum

1 reference

12 December 2020

S100B protein is released by in vitro trauma and reduces delayed neuronal injury

1 reference

12 December 2020

General and dramatic glial reaction in Alzheimer brains

1 reference

12 December 2020

Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor

1 reference

12 December 2020

Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo

1 reference

12 December 2020

Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues

1 reference

12 December 2020

Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors

1 reference

12 December 2020

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

1 reference

12 December 2020

Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms

1 reference

12 December 2020

Tumor Necrosis Factor-Induced Proliferation of Astrocytes from Mature Brain Is Associated with Down-Regulation of Glial Fibrillary Acidic Protein mRNA

1 reference

12 December 2020

Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type.

1 reference

12 December 2020

Intracellular and extracellular roles of S100 proteins

1 reference

12 December 2020

Differential effects of cytokines and redox potential on glutamate uptake in rat cortical glial cultures

1 reference

12 December 2020

S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo

1 reference

12 December 2020

TNF-alpha induced over-expression of GFAP is associated with MAPKs

1 reference

12 December 2020

S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation.

1 reference

12 December 2020

Secretion of S-100 from rat C6 glioma cells.

1 reference

12 December 2020

S100 beta protects hippocampal neurons from damage induced by glucose deprivation

1 reference

12 December 2020

Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease.

1 reference

12 December 2020

Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology.

1 reference

12 December 2020

Glial fibrillary acidic protein in the cerebrospinal fluid of patients with dementia.

1 reference

12 December 2020

S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures.

1 reference

12 December 2020

Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis

1 reference

12 December 2020

Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia

1 reference

12 December 2020

Cytokine effects on glutamate uptake by human astrocytes

1 reference

12 December 2020

Inflammatory factors are elevated in brain microvessels in Alzheimer's disease

1 reference

12 December 2020

Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients.

1 reference

12 December 2020

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

12 December 2020

Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome

1 reference

12 December 2020

S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.

1 reference

12 December 2020

Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease

1 reference

12 December 2020

Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B.

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Astrocyte hypertrophy in the Alzheimer's disease hippocampal formation

1 reference

12 December 2020

Endogenous glutathione and catalase protect cultured rat astrocytes from the iron-mediated toxicity of hydrogen peroxide.

1 reference

12 December 2020

S100 beta as a neurotrophic factor

1 reference

12 December 2020

Cytokine modulation of glial glutamate uptake: a possible involvement of nitric oxide.

1 reference

12 December 2020

Evidence for apoptotic cell death in Alzheimer's disease.

1 reference

12 December 2020

S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions.

1 reference

12 December 2020

Tumor Necrosis Factor‐α and Basic Fibroblast Growth Factor Decrease Glial Fibrillary Acidic Protein and Its Encoding mRNA in Astrocyte Cultures and Glioblastoma Cells

1 reference

12 December 2020

The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia.

1 reference

12 December 2020

Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology

1 reference

12 December 2020

10.1007/S00702-006-0479-5

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018